AN ORAL SYNDROME COMPLICATING PSYCHOPHARMACOTHERAPY: STUDY II.
D000666:Amphotericin B; D000928:Antidepressive Agents; D002180:Candidiasis, Oral; D002181:Candidiasis, Vulvovaginal; D004358:Drug Therapy; D001523:Mental Disorders; D009761:Nystatin; D009912:Oral Manifestations; D014116:Toxicology; D014149:Tranquilizing Agents; D014987:Xerostomia
D000928:Antidepressive Agents; D014149:Tranquilizing Agents; D009761:Nystatin; D000666:Amphotericin B
AMPHOTERICIN B; ANTIDEPRESSIVE AGENTS; DRUG THERAPY; MENTAL DISORDERS; MONILIASIS, ORAL; MONILIASIS, VULVOVAGINAL; NYSTATIN; ORAL MANIFESTATIONS; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; XEROSTOMIA